Basement membrane patterns, gelatinase A and tissue inhibitor of metalloproteinase-2 expressions, and stromal fibrosis during the development of peripheral lung adenocarcinoma

Human Pathology

Volumn 30, Issue 3, 1999, Pages 331-338

  Kitamura, Hitoshi ^a   Oosawa, Yukihiro ^b   Kawano, Naomi ^b   Kameda, Yoichi ^b   Hayashi, Hiroyuki ^b   Nakatani, Yukio ^b   Udaka, Naoko ^b   Ito, Takaaki ^b   Miyazaki, Kaoru ^b  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

^b NONE

Author keywords

Basement membrane; Gelatinase A; Lung adenocarcinoma; Stromal fibrosis; Tissue inhibitor of metalloproteinases 2

Indexed keywords

GELATINASE A; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ARTICLE; BASEMENT MEMBRANE; CANCER INVASION; CARCINOMA IN SITU; CELL HYPERPLASIA; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOARCHITECTURE; FIBROSIS; HUMAN; HUMAN TISSUE; LUNG ADENOCARCINOMA; LUNG ALVEOLUS CELL CARCINOMA; PROTEIN EXPRESSION; SCAR FORMATION; STROMA;

EID: 0033023821     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0046-8177(99)90013-8     Document Type: Article

References (34)

1. Barsky SH, Siegal GP, Jannotta F, et al: Loss of basement membrane components by invasive tumors but not by their benign counterparts. Lab Invest 49:140-147, 1983
2. Birembaut P, Caron Y, Adnet J-J: Usefulness of basement membrane markers in tumoural pathology. J Pathol 145:283-296, 1985
3. Chu Y-W, Yang P-C, Yang S-C, et al: Selection of invasive and metastatic subpopulations from a human lung adenocarcinoma cell line. Am J Respir Cell Mol Biol 17:353-360, 1997
4. Jones JL, Walker RA: Control of matrix metalloproteinase activity in cancer. J Pathol 183:377-379, 1997
5. Stetler-Stevenson WG, Aznavoorian S, Liotta LA: Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu Rev Cell Biol 9:541-573, 1993
6. Travis WD, Travis LB, Devesa SS: Lung cancer. Cancer 75:191-202, 1995
7. Barsky SH, Cameron R, Osann KE, et al: Rising incidence of bronchioloalveolar lung carcinoma and its unique clinicopathologic features. Cancer 73:1163-1170, 1994
8. Kitamura H, Kameda Y, Nakamura N, et al: Atypical adenomatous hyperplasia and bronchoalveolar lung carcinoma: Analysis by morphometry and the expressions of p53 and carcinoembryonic antigen. Am J Surg Pathol 20:553-562, 1996
9. Slebos RJC, Baas IO, Clement MJ, et al: p53 alterations in atypical alveolar hyperplasia of the human lung. HUM PATHOL 29:801-808, 1998
10. Shimosato Y, Hashimoto T, Kodama T, et al: Prognostic implications of fibrotic focus (scar) in small peripheral lung cancers. Am J Surg Pathol 4:365-373, 1980
11. Noguchi M, Morikawa A, Kawasaki M, et al: Small adenocarcinoma of the lung: Histologic characteristics and prognosis. Cancer 75:2844-2852, 1995
12. Matsui K, Kitagawa M, Sugiyama S, et al: Distribution pattern of the basement membrane components is one of the significant prognostic correlates in peripheral lung adenocarcinomas. HUM PATHOL 26:186-194, 1995
13. Eto T, Suzuki H, Honda A, et al: The changes of the stromal elastotic framework in the growth of peripheral lung adenocarcinomas. Cancer 77:646-656, 1996
14. Nishino T, Ishida T, Oka T, et al: Prognostic significance of laminin in adenocarcinoma of the lung. J Surg Oncol 43:214-218, 1990
15. Watanabe N, Nakajima I, Abe S, et al: Staining pattern of type IV collagen and prognosis in early stage adenocarcinoma of the lung. J Clin Pathol 47:613-615, 1994
16. Sukoh N, Abe S, Nakajima I, et al: Immunohistochemical distributions of cathepsin B and basement membrane antigens in human lung adenocarcinoma: Association with invasion and metastasis. Virchows Arch 424:33-38, 1994
17. Tokuraku M, Sato H, Murakami S, et al: Activation of the precursor of gelatinase A/72 kDa type IV collagenase/MMP-2 in lung carcinomas correlates with the expression of membrane-type matrix metalloproteinase (MT-MMP) and with lymph node metastasis. Int J Cancer 64:355-359, 1995
18. Clarke MR, Landreneau RJ, Finkelstein SD, et al: Extracellular matrix expression in metastasizing and nonmetastasizing adenocarcinomas of the lung. HUM PATHOL 28:54-59, 1997
19. Grigioni WF, Biagini G, Garbisa S, et al: Immunohistochemical study of basement membrane antigens in bronchioloalveolar carcinoma. Am J Pathol 128:217-224, 1987
20. Ohori NP, Yousem SA, Griffin J, et al: Comparison of extracellular matrix antigens in subtypes of bronchioloalveolar carcinoma and conventional pulmonary adenocarcinoma: An immunohistochemical study. Am J Surg Pathol 16:675-686, 1992
21. Higashiyama M, Doi O, Kodama K, et al: Cathepsin B expression in tumour cells and laminin distribution in pulmonary adenocarcinoma. J Clin Pathol 46:18-22, 1993
22. World Health Organization: International histological classifications of tumours. No. 1, in Histological Typing of Lung Tumors (ed 2). Geneva, Author, 1981
23. Clayton F: The spectrum and significance of bronchioloalveolar carcinomas. Pathol Annu 23:361-394, 1988
24. Kawano N, Osawa H, Ito T, et al: Expression of gelatinase A, tissue inhibitor of metalloproteinases-2, matrilysin, and trypsin (ogen) in lung neoplasms: An immunohistochemical study. HUM PATHOL 28:613-622, 1997
25. Pääkkö P, Risteli J, Risteli L, et al: Immunohistochemical evidence that lung carcinomas grow on alveolar basement membranes. Am J Surg Pathol 14:464-473, 1990
26. ten Velde GPM, Havenith MG, Volovics A, et al: Prognostic significance of basement membrane deposition in operable squamous cell carcinomas of the lung. Cancer 67:3001-3005, 1991
27. Nakagawa H, Yagihashi S: Expression of type IV collagen and its degrading enzymes in squamous cell carcinoma of lung. Jpn J Cancer Res 85:934-938, 1994
28. Soini Y, Pääkkö P, Autio-Harmainen H: Genes of laminin B1 chain, α1 (IV) chain of type IV collagen, and 72-kd type IV collagenase are mainly expressed by the stromal cells of lung carcinomas. Am J Pathol 142:1622-1630, 1993
29. Afzal S, Lalani E-N, Foulkes WD, et al: Matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression and synthetic matrix metalloproteinase-2 inhibitor binding in ovarian carcinomas and tumor cell lines. Lab Invest 74:406-421, 1996
30. Grignon DJ, Sakr W, Toth M, et al: High levels of tissue inhibitor of metalloproteinase-2 (TIMP-2) expression are associated with poor outcome in invasive bladder cancer. Cancer Res 56:1654-1659, 1996
31. Strongin AY, Collier I, Bannikov G, et al: Mechanism of cell surface activation of 72-kDa type IV collagenase: Isolation of the activated form of the membrane metalloprotease. J Biol Chem 270:5331-5338, 1995
32. Nemeth JA, Goolsby CL: TIMP-2, a growth-stimulatory protein from SV40-transformed human fibroblasts. Exp Cell Res 207:376-382, 1993
33. Hayakawa T, Yamashita K, Ohuchi E, et al: Cell growth-promoting activity of tissue inhibitor of metalloproteinase-2 (TIMP-2). J Cell Sci 107:2373-2379, 1994
34. Liabakk N-B, Talbot I, Smith RA, et al: Matrix metalloprotease 2 (MMP-2) and matrix metalloprotease 9 (MMP-9) type IV collagenases in colorectal cancer. Cancer Res 56:190-196, 1996